Box plots of the three-dimensional displacement variations and the COR. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

Diagram of displacement variation. by Yifei Li (198040)

Subjects:

Scheme and results of orthogonal test. by Yifei Li (198040)

Subjects:

Comparison between simulation tests and bench tests. by Yifei Li (198040)

Subjects:

The millet mode. by Yifei Li (198040)

Subjects:

Representative CEUS images with BR55 of mice with a subcutaneous tumour allograft (arrows) under treatment. by Felix L. Herr (21544362)

Subjects:

Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Subjects:

Representative immunohistochemical stainings. by Felix L. Herr (21544362)

Subjects:

ROI selection. by Felix L. Herr (21544362)

Subjects:

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Subjects:

SDI-based age-standardized rates of DALYs and ASDR for IHD attributable to HSBP. by Zhenhua Zhuang (11192745)

Subjects:

Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx by Guodong Huang (1595956)

“…The clinical relevance assays and experimental validation showed SESN1 as a clinical significance target of miR-183-3p.</p>Discussion<p>Our study lays the foundation for investigating miRNAs with diagnostic significance in early-stage LUAD, pointing out that inhibition of miR-183-3p may serve as a novel therapeutic in LUAD.…”

Group control-after intervention. by Nan Tang (642590)

Subjects:

Flowchart of literature screening process. by Shangtian Wang (20933822)

Subjects:

Seasonal Influenza activity from 2020-2023 in Southeast Asia and Southern Asia. by Nadia Nisar (311028)

Subjects:

The details of literature inclusion and exclusion. by Shangtian Wang (20933822)

Subjects:

Samples Tested and Positive Samples During Pre- and Post-Pandemic Periods. by Nadia Nisar (311028)

Subjects: